The SPAC vs Direct Listing Decision Tree for 2026 Founders

The SPAC vs Direct Listing Decision Tree for 2026 Founders

You've built something real. Revenue is north of $50M, your Series C is closed, and your board is asking the question: what's next? IPO, SPAC, or direct listing?

Three years ago, the answer was clearer. SPACs were the hot bet-faster, cheaper, less scrutiny. Then the market corrected hard. IPOs returned to favor. Direct listings remained the overlooked middle child, favored by a handful of founders who understood the math.

In 2026, the landscape has shifted again. SPACs are back, but different. Direct listings are more accessible. IPOs are still the traditional path, but increasingly questioned. This article cuts through the noise with a decision tree, real numbers, and the mechanics each path demands.

If you're a late-stage founder weighing these options, this is the framework you need.

Why This Decision Matters More Than You Think

Choosing how to go public is not just a financial transaction. It shapes your company's next decade-your ability to acquire, your stock-based compensation structure, your founder liquidity timeline, and your relationship with public markets.

The three paths differ on five critical dimensions:

Capital raised. SPACs and IPOs let you raise primary capital (new money for the company). Direct listings do not. You're selling existing shares; the company gets nothing.

Timeline. SPACs move fastest (6-12 months). Direct listings are moderate (3-6 months). IPOs are slowest (9-18 months).

Dilution. SPACs carry sponsor dilution (typically 20% of post-transaction equity). IPOs dilute you by the amount you raise. Direct listings have no dilution-you're not creating new shares.

Price discovery. IPOs use a fixed price set by underwriters. Direct listings and SPACs use market-based pricing, though mechanisms differ.

Scrutiny. IPOs face the most regulatory and investor due diligence. Direct listings are lighter. SPACs have evolved-they now face IPO-level scrutiny, but the timeline is still faster.

Understanding these tradeoffs is where the real work begins. Let's walk through the decision tree.

The Foundational Question: Do You Need New Capital?

This is where the tree branches first.

If you need $500M to $2B in fresh capital-to fund aggressive expansion, major acquisitions, or R&D-a direct listing is off the table. You need either a SPAC or an IPO. Both allow primary offerings (new shares sold to raise capital for the company).

If your balance sheet is healthy and you don't need capital, or you only need modest amounts ($50M-$200M), a direct listing becomes viable. You're selling existing shares (founder, early employee, and investor shares), and the proceeds go to shareholders-not the company. This is actually a feature, not a bug, for well-capitalized founders.

As outlined in 11 Capital Raising Playbooks for Startup Founders, the mechanics of capital structure matter deeply at this stage. Understanding your cap table and who holds what before you go public is non-negotiable.

Decision point: Need $500M+? SPAC or IPO. Need <$200M? All three are viable. Need $200M-$500M? Likely IPO or SPAC.

The SPAC Path: Faster, But the Sponsor Tax Is Real

A SPAC (Special Purpose Acquisition Company) is a blank-check shell company. It raises money from public investors, then merges with a private company-you-to take it public.

The appeal is obvious: speed. A SPAC can move from LOI (letter of intent) to public company in 6-9 months. An IPO takes 12-18 months. That matters if you're in a market window or if you want to capitalize on investor appetite quickly.

But the sponsor tax is substantial. SPAC sponsors typically receive 20% of the company's equity (called "promote" or "founder shares") for putting the deal together. This dilutes your ownership immediately. If you own 10% pre-SPAC, you own roughly 8% post-SPAC (assuming no dilution elsewhere).

Additionally, SPACs charge transaction fees: legal, advisory, and sponsor fees can run $20M-$50M, depending on deal size. An IPO costs similar amounts, but the fee structure is different-underwriters take a percentage of capital raised, not a fixed fee.

SPAC Mechanics: A Real Example

Let's say you're a $5B valuation company. You're raising $1B in capital to fund expansion. Here's how a SPAC merger works:

1. SPAC raises capital. The SPAC has already raised, say, $800M from public investors. These are held in trust.
2. Your company merges into the SPAC. You and your investors own your company; the SPAC is now the public shell.
3. Sponsor gets 20% promote. The SPAC sponsors receive 20% of the post-merger company (diluting everyone else by ~16.7%).
4. You raise additional capital. You issue $1B in new shares to new investors (PIPE investors-private investors in public equity). This raises capital for your company.
5. Redemptions happen. Public shareholders who don't like the deal can redeem their shares for cash. If too many redeem, the deal breaks (this is a real risk).
6. You're public. Your company is now listed on Nasdaq or NYSE.

Net result: You raised $1B, but you've diluted existing shareholders by 20% (sponsor) plus the $1B raise (roughly 17% more, depending on post-money valuation). Your ownership stake shrinks, but your company has fresh capital and is public.

As discussed in All-In Podcast Insights: What David Sacks Really Advises Founders About Valuations in 2025, valuation discipline matters at this stage. SPACs can obscure true valuation because the sponsor's 20% is often not clearly communicated to public shareholders.

When SPACs Make Sense

SPACs are attractive if:

• You're in a time-sensitive market. AI startups in 2023, fintech in 2021-if your category is hot and you're worried about the window closing, SPAC speed matters.
• You want to raise significant capital quickly. SPACs can close capital raises faster than IPOs because the underwriting and pricing are less formal.
• You have a strong SPAC sponsor. The sponsor's reputation, network, and ability to attract PIPE investors matter enormously. A top-tier sponsor (e.g., Thoma Bravo, Gores Holdings) brings credibility and investor relationships.
• Your narrative is compelling but unconventional. SPACs are sometimes more flexible on companies that don't fit traditional IPO boxes (e.g., pre-revenue deep tech, unprofitable growth companies).

But SPACs carry risks:

• Redemption risk. If public shareholders redeem more than expected, the deal can collapse or the capital raised shrinks. This happened to dozens of SPACs in 2022-2023.
• Sponsor incentive misalignment. Sponsors want to close deals; they get paid regardless of post-merger performance. This creates perverse incentives.
• Regulatory scrutiny. The SEC has tightened SPAC rules. Forward-looking statements are now heavily scrutinized. SPACs no longer have the regulatory "free pass" they once did.
• Public market perception. Many institutional investors now avoid SPACs or demand heavy discounts. The stigma from failed SPAC mergers (WeWork, Nikola, etc.) lingers.

As noted in SPACs Reemerge as a Viable Path to the Public Markets, the 2026 SPAC market is smaller and more disciplined than 2021. Sponsors are more selective, and investors are more skeptical. The deals that work are those with strong sponsors, clear narratives, and realistic projections.

The Direct Listing Path: No Dilution, But No Capital Raise

A direct listing is the simplest path to public markets. Your company lists directly on an exchange. No IPO process, no SPAC merger, no underwriter pricing. Existing shareholders (founders, employees, early investors) can sell their shares on day one. The company raises zero dollars.

This sounds too good to be true. Why wouldn't every company do this?

Because most companies going public need capital. And direct listings don't provide it.

However, if you've already raised enough capital, or if you're profitable and generating cash, a direct listing is elegant. Spotify went public via direct listing in 2018. Slack did in 2019. Coinbase in 2021. All three were well-capitalized, profitable or near-profitable, and didn't need IPO capital.

Direct Listing Mechanics

Here's how it works:

1. You file with the SEC. You register your shares to be publicly traded, just like an IPO.
2. No underwriter pricing. Unlike an IPO, there's no roadshow, no book-building, no fixed price set by underwriters. Price discovery happens on the open market.
3. Day one trading. Your company opens for trading. The first trades set the price.
4. Shareholders can sell. Founders, employees, and early investors can sell shares immediately (subject to lock-up agreements, which are typically 180 days for insiders).
5. Company raises zero dollars. All proceeds go to selling shareholders, not the company.

The beauty of this is price discovery. Unlike an IPO, where underwriters set a price and the stock often pops (or crashes) on day one, a direct listing's opening price reflects real market demand. Spotify opened at $132 (no predetermined price) and closed at $165.90 on its first day. The price was set by buyers and sellers, not bankers.

When Direct Listings Make Sense

Direct listings are ideal if:

• You don't need capital. Your balance sheet is strong, you're cash-flow positive, or you've already raised enough to fund your plans.
• You want price discovery. You believe your company's true value will be discovered by markets, not set by underwriters.
• You want simplicity. Direct listings are faster (3-6 months) and cheaper (lower fees) than IPOs.
• You want to reward employees. Employees can sell shares on day one, providing immediate liquidity. This is huge for retention and morale.
• You're established and profitable. The SEC and investors are more comfortable with direct listings for mature companies with clear business models.

But direct listings have constraints:

• No primary capital. You can't raise money for the company. If you need capital, you must raise it separately (private funding round).
• More regulatory flexibility needed. The SEC has been cautious about direct listings for unprofitable, high-growth companies. You need a clear, defensible business model.
• Smaller float. Direct listings typically have smaller floats (fewer shares trading) than IPOs, which can mean lower liquidity and wider bid-ask spreads.
• Less underwriter support. IPO underwriters actively support the stock in the aftermarket. Direct listings have no such support. Your stock is on its own.

As outlined in How to Evaluate the Three Paths to the Public Markets, direct listings are the least expensive option, with fees typically 3-5% of capital raised (or a flat fee if no capital is raised). IPOs run 3-7% of capital raised. SPACs are more opaque but often fall in the 5-10% range when all fees are included.

The IPO Path: The Gold Standard, But Slowest

An IPO (Initial Public Offering) is the traditional path. You hire underwriters (Goldman Sachs, Morgan Stanley, etc.), they take your company on a roadshow, they set a price, and you go public.

IPOs are slower (12-18 months), more expensive (higher underwriter fees), and more heavily scrutinized. But they're also the most prestigious, the most liquid, and the path most institutional investors expect.

IPO Mechanics

1. You hire underwriters. These are investment banks that will manage the process.
2. You file an S-1. This is a detailed registration statement with your financials, business model, risks, and management team.
3. SEC review. The SEC reviews your S-1, asks questions, and you revise. This takes months.
4. Roadshow. Your CEO and CFO travel to meet institutional investors, pitch the company, and answer questions.
5. Book-building. Underwriters collect orders from investors at different price points, building a "book" of demand.
6. Pricing. Based on the book, underwriters set a price. This price is typically below what they expect the stock to trade at (creating the "pop").
7. Lock-up. Insiders (founders, employees, early investors) agree not to sell shares for 180 days. This prevents a flood of selling post-IPO.
8. Trading begins. Your stock trades on Nasdaq or NYSE.

When IPOs Make Sense

IPOs are the right choice if:

• You need significant capital. You're raising $500M or more, and you want the most reliable path to that capital.
• You're in a conservative industry. Biotech, healthcare, financial services-industries where investors expect IPOs, not SPACs.
• You want institutional credibility. Large mutual funds, pension funds, and other institutions often won't touch SPACs or direct listings. An IPO is the gold standard.
• You're profitable or near-profitable. IPOs work best for companies with clear business models and path to profitability.
• You can wait. You have 12-18 months and don't need capital urgently.

IPO downsides:

• Time and cost. The process is long and expensive. You'll spend $10M-$50M on legal, accounting, and underwriter fees.
• Disclosure burden. You'll be heavily scrutinized. Your financials, business model, and risks will be public knowledge.
• Underwriter control. Underwriters have significant power over your IPO narrative and pricing. They can push you toward profitability or growth, depending on what sells.
• Lock-up period. Insiders can't sell for 180 days, which can create a selling wall when the lock-up expires.

As discussed in 6 Pitch Deck Red Flags: What to Avoid in Your Quest for Venture Capital, the narrative and story matter deeply when going public. IPO underwriters are very focused on the story-the market opportunity, your competitive advantage, your path to profitability. A weak narrative can sink an IPO or force you to lower your valuation.

The Decision Tree: A Step-by-Step Framework

Here's how to navigate the choice:

Step 1: Capital Needs

Question: How much capital do you need in the next 3-5 years?

• $0-$200M: Direct listing is viable. You can also do SPAC or IPO if you want.
• $200M-$500M: SPAC or IPO. Direct listing is not ideal (you'd need to raise capital separately).
• $500M+: IPO or SPAC. IPO is more reliable for this amount; SPAC works if you have a strong sponsor.

Step 2: Timeline

Question: How urgent is going public?

• 6-9 months: SPAC is your best bet. Direct listing is possible if you're ready. IPO is too slow.
• 9-18 months: IPO or SPAC. Direct listing is possible if you don't need capital.
• 18+ months: All paths are viable. You have time to optimize.

Step 3: Market Conditions

Question: Is your sector hot? Are investors buying?

• Hot sector, investor appetite: SPAC can work if you have a strong sponsor. IPO is strong. Direct listing works if you're profitable.
• Cold sector, skeptical investors: IPO is your safest bet (most credible). SPAC is risky (high redemption risk). Direct listing is risky (might not get good pricing).

Step 4: Company Profile

Question: Are you profitable? Do you have a clear business model?

• Profitable or near-profitable: All three paths work. Direct listing is ideal (cheapest, simplest).
• High-growth, unprofitable: IPO or SPAC. Direct listing is harder (SEC is skeptical).
• Early-stage, pre-revenue: SPACs are more flexible (though this is changing). IPOs are very hard. Direct listings are off the table.

Step 5: Founder Preferences

Question: What matters most to you?

• Speed: SPAC.
• Simplicity and cost: Direct listing.
• Credibility and capital: IPO.
• Founder liquidity: Direct listing (day one selling) or SPAC (PIPE investors often include founder-friendly terms).
• Employee retention: Direct listing (employees can sell day one) or SPAC (if PIPE terms are founder-friendly).

Real-World Examples: 2025-2026

Let's apply this framework to recent examples.

Example 1: A Profitable SaaS Company ($100M ARR, $50M Valuation)

Capital needs: Minimal. The company is growing 40% YoY and is cash-flow positive.

Timeline: The founder wants to go public within 12 months.

Market: SaaS is solid, not hot. Investors are selective.

Profile: Profitable, clear business model, strong unit economics.

Decision: Direct listing. The company doesn't need capital, so a direct listing is ideal. It's the cheapest path (fees are minimal), the fastest (3-6 months), and it rewards employees with immediate liquidity. The founder can sell shares on day one if desired. An IPO would work, but it's overkill-you're paying for capital you don't need. A SPAC would dilute you by 20% for capital you don't need.

Example 2: A High-Growth AI Company ($20M ARR, $500M Valuation, Unprofitable)

Capital needs: Significant. The company needs $300M to fund expansion, hiring, and R&D.

Timeline: The founder wants to go public within 18 months. The AI market is hot, but it's cooling.

Market: AI is still hot, but investor skepticism is rising. Profitability is now expected.

Profile: High-growth, unprofitable, but clear path to profitability.

Decision: IPO. The company needs significant capital, so a direct listing is off the table. A SPAC could work if you have a strong sponsor (e.g., Thoma Bravo, Gores Holdings), but IPO is safer. The IPO underwriters will help you tell the story (AI, growth, path to profitability). They'll work with you to reach the right investors. The process is slower (12-18 months), but it's the most reliable path to $300M+ capital.

Alternatively, if you have a strong SPAC sponsor and you're willing to accept some redemption risk, a SPAC could work. The timeline would be faster (6-12 months), and you might get a better price (less underwriter control). But the sponsor dilution (20%) and redemption risk make IPO the safer choice.

Example 3: A Fintech Company ($50M ARR, $300M Valuation, Approaching Profitability)

Capital needs: Moderate. The company needs $100M-$150M to fund expansion and M&A.

Timeline: The founder is flexible. The fintech market is solid but not hot.

Market: Fintech is stable. Investors are selective but not hostile.

Profile: Growing, approaching profitability, clear business model.

Decision: IPO or SPAC. Both work. IPO is the safer, more credible path. It will take 12-18 months, but you'll have strong institutional support and a reliable capital raise. A SPAC could work if you have a strong sponsor, but fintech investors are often conservative-they prefer IPOs. The timeline would be faster (6-12 months), but the sponsor dilution and potential redemption risk might not be worth it.

A direct listing is not ideal here because you need $100M-$150M in capital, and direct listings don't provide that.

Practical Considerations: The Things Your Banker Won't Tell You

Beyond the mechanics, there are practical realities that matter.

Underwriter Relationships

If you're doing an IPO, your choice of underwriters matters enormously. Goldman Sachs and Morgan Stanley are the top tier, but they're selective. If you're not a household name or a blockbuster deal, they might not be interested. Second-tier underwriters (e.g., Jefferies, Evercore) are more accessible and often better partners for mid-market companies.

For SPACs, the sponsor is everything. A top-tier sponsor (Thoma Bravo, Gores Holdings, Pershing Square) brings credibility, PIPE investors, and operational support. A no-name sponsor is a red flag.

Lock-up Agreements

IPOs typically have 180-day lock-ups for insiders. SPACs sometimes have shorter lock-ups or more flexible terms. Direct listings have lock-ups, but they're often negotiable. If you need founder liquidity quickly, negotiate lock-up terms early.

Dilution Math

Understand the full dilution impact:

• IPO: You dilute by the amount of capital raised (as a % of post-money valuation).
• SPAC: You dilute by 20% (sponsor) plus the amount of capital raised.
• Direct listing: No dilution.

If you're raising $200M on a $1B valuation (IPO), you dilute by 16.7%. If you're doing a SPAC, you dilute by 20% (sponsor) plus 16.7% (capital raise), roughly 33% total.

As discussed in AI Startup Valuations: The Reality Check You Need for Fundraising Success, valuation discipline is critical. Don't overpay for speed or underestimate dilution.

Post-IPO Life

Going public is not the finish line. It's the start of a new game. You'll face quarterly earnings calls, activist investors, analyst scrutiny, and regulatory compliance. Your stock price will fluctuate. Your employees' equity will fluctuate. You'll have less control over your narrative.

Some founders thrive in this environment. Others hate it. Know yourself.

As outlined in 10 Fundraising Myths Founders Still Believe (And the Truth), going public is not the ultimate validation. It's a tool. Use it wisely.

Sector-Specific Guidance

Your sector influences the optimal path.

Biotech/Healthcare: IPO is the gold standard. Investors expect it. Regulatory scrutiny is high, so the IPO process's rigor is an advantage. SPACs have a bad reputation in biotech after several failures. Direct listings are rare.

SaaS/Software: All three paths work. If you're profitable, direct listing is ideal. If you need capital, IPO or SPAC both work. SaaS investors are pragmatic-they care about unit economics, not the path to public markets.

Fintech: IPO is preferred. Fintech investors are often conservative. They want regulatory credibility. A SPAC can work if the sponsor is strong (e.g., Pershing Square). Direct listings are possible if you're profitable.

AI/Deep Tech: SPAC or IPO. AI investors are growth-focused and will accept unprofitable companies. SPACs are attractive because they're faster and more flexible on narrative. IPOs work if you have a compelling story. Direct listings are hard (you need profitability or very clear path to it).

Consumer/E-commerce: IPO or SPAC. Both work. Direct listings are possible if you're profitable. Consumer investors are narrative-driven; they care about growth and brand. SPACs can work if the sponsor understands consumer.

Infrastructure/Enterprise: IPO is preferred. Enterprise investors are conservative. They want credibility and institutional support. SPACs are possible but less common. Direct listings are rare.

As noted in 6 Sectors That Are Thriving to Raise Capital in 2024, sector dynamics change. AI was hot in 2023-2024. Climate tech is heating up. Biotech is cyclical. Stay attuned to sector sentiment when making your decision.

2026 Market Outlook: What's Changed?

The 2026 market for going public is different from 2021 or even 2023.

SPACs are back, but disciplined. After the 2021-2022 SPAC boom and bust, the market has matured. Sponsors are more selective. Investors are more skeptical. Redemption rates are higher. But for the right deal (strong sponsor, clear narrative, realistic projections), SPACs are viable and fast.

IPOs are steady. The traditional IPO process remains the gold standard for companies with strong fundamentals, clear business models, and significant capital needs. Underwriter fees have normalized. Timeline is still 12-18 months.

Direct listings are gaining acceptance. More companies are choosing direct listings. The SEC has clarified rules. Investors are more comfortable. For profitable companies that don't need capital, direct listings are increasingly attractive.

Regulatory scrutiny is higher. The SEC is paying more attention to SPACs, particularly forward-looking statements. IPO underwriters are more conservative on projections. Direct listing companies need clear, defensible business models.

Founder liquidity is a bigger priority. Founders are asking for earlier liquidity. Direct listings enable this (day one selling). SPACs sometimes do (through PIPE terms). IPOs require waiting for lock-up expiration.

As discussed in SPACs Reemerge as a Viable Path to the Public Markets, the 2026 SPAC market is smaller but more mature. Deals that work are those with strong sponsors, clear narratives, and realistic projections. Deals that fail are those with weak sponsors, hype narratives, and inflated projections.

The Checklist: Are You Ready?

Before you commit to any path, ask yourself:

Financial readiness:

• Do you have 2+ years of audited financials?
• Do you understand your cap table and dilution impact?
• Have you modeled your cash needs for the next 3-5 years?
• Do you know how much capital you actually need?

Operational readiness:

• Do you have a strong CFO and finance team?
• Can you handle quarterly earnings calls and investor relations?
• Is your business model clear and defensible?
• Do you have strong unit economics (if SaaS/software) or clear path to profitability?

Governance readiness:

• Do you have a strong board?
• Do you have independent directors (required for IPO)?
• Do you have audit and compensation committees?
• Are you comfortable with governance requirements?

Market readiness:

• Is your sector in favor with investors?
• Do you have a compelling narrative?
• Do you have strong investor relationships (for IPO roadshow)?
• Is there demand for your company's stock?

If you're checking most of these boxes, you're ready to start the process. If not, you might need more time in the private markets.

As outlined in 5 Steps to Create an Outstanding Capital Raising Plan [Free Templates], planning is critical. Don't rush into going public. Plan your capital raising strategy years in advance.

The Final Decision: Which Path Is Right for You?

Here's the distilled framework:

Choose SPAC if:

• You need capital ($200M-$1B+).
• You're in a hot sector with strong investor appetite.
• You have a strong sponsor relationship.
• You want speed (6-12 months).
• You can tolerate sponsor dilution (20%) and redemption risk.

Choose IPO if:

• You need significant capital ($500M+).
• You want the most credible, prestigious path.
• You're in a conservative industry (biotech, healthcare, fintech).
• You have a clear business model and path to profitability.
• You can wait 12-18 months.

Choose Direct Listing if:

• You don't need capital (or need minimal capital).
• You're profitable or near-profitable.
• You want the simplest, cheapest path.
• You want to reward employees with immediate liquidity.
• You want price discovery (market-based pricing).

There's no single "right" answer. The right path depends on your capital needs, timeline, market conditions, company profile, and founder preferences. Use this framework to think through each dimension. Then talk to advisors, underwriters, and SPAC sponsors. Get real data. Make an informed decision.

As discussed in 200 Reasons to Raise Capital for Your Startup, going public is a major milestone. It's exciting, it's complex, and it's permanent (mostly). Make sure you're doing it for the right reasons and via the right path.

Next Steps: From Decision to Execution

Once you've decided on a path, the real work begins.

For SPAC: Start building relationships with SPAC sponsors. Understand their track record, their investor base, and their operational support. Get comfortable with the sponsor dilution. Model redemption scenarios (what if 50% of public shareholders redeem?). Work with legal counsel on merger agreements and PIPE terms.

For IPO: Hire a strong lead underwriter (or two). Assemble your S-1 team (lawyers, accountants, IR advisors). Start preparing your financials for SEC scrutiny. Build your investor relations strategy. Plan your roadshow narrative.

For Direct Listing: Ensure your business is truly public-ready (profitable or clear path to profitability). Understand SEC rules for direct listings. Work with your underwriter on pricing expectations. Plan your employee communication strategy (many employees will want to sell on day one).

In all cases, work with experienced advisors. This is not a DIY process. Hire the best lawyers, accountants, and underwriters you can afford. They'll save you money and headaches.

As outlined in 5 Proven Strategies to Raise Private Money for Your Startup, the journey to going public is long. It starts years before the actual transaction. Build strong investor relationships. Maintain clean cap tables. Execute on your business plan. By the time you're ready to go public, the path will be clear.

Conclusion: The Path Forward

SPACs, direct listings, and IPOs are three distinct paths to public markets. Each has merits and tradeoffs. There's no universal right answer-only the right answer for your company, at your moment, with your constraints.

Use this decision tree to think systematically. Do you need capital? How much? How urgently? Is your sector hot? Are you profitable? What matters most to you-speed, cost, credibility, or simplicity?

Answer these questions honestly. Then choose your path. Execute with discipline. And remember: going public is a means to an end, not the end itself. The real work-building a great company, serving customers, creating value-starts after you're public.

For more on fundraising strategy and capital raising mechanics, explore Raise Capital Without Warm Intros: The AI-Personalized Cold Outreach Blueprint (Templates, Cadence, Compliance) That Actually Gets Replies and dive deeper into 11 Templates for Crafting a Killer Problem Statement That Raises Millions (Yes, Millions!) to ensure your narrative is compelling before you approach any path to public markets.

The 2026 public markets are open. Choose wisely.